Trial Profile
Randomised, Double-blind, Placebo-controlled, Multicentre, Comparative Phase II Pilot Study on the Efficacy and Tolerability of an 8-week Rectal Treatment With 2 mg Budesonide or Placebo for the Prevention of Acute Radiation Proctitis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2014
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Proctitis
- Focus Therapeutic Use
- Sponsors Dr Falk Pharma
- 05 Nov 2014 New trial record